Cost-Effectiveness of Smoking Cessation Interventions Integrated Into Lung Cancer Screening - Report - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Economic Evaluation of Smoking Cessation Strategies within Lung Cancer Screening Programs

  • By

  • Pianpian Cao

  • Laney Smith

  • Emma Tian

  • Lou-Anne Chichester

  • Elizabeth Schofield

  • Randi M. Williams

  • Rafael Meza

  • Benjamin A. Toll

  • Jamie Ostroff

  • Elena B. Elkin

  • Steven S. Fu

  • Stephanie R. Land

  • Kathryn L. Taylor

  • Jinani Jayasekera

  • September 14, 2026

Share

Economic Evaluation of Smoking Cessation Strategies within Lung Cancer Screening Programs

Background

Lung cancer remains a leading cause of cancer mortality in the US, with over 80% of cases linked to smoking. The integration of smoking cessation interventions into lung cancer screening programs is crucial for enhancing patient outcomes. Recent guidelines from the US Preventive Services Task Force emphasize the importance of concurrent cessation support for individuals eligible for lung cancer screening.

Data Highlights

No specific numerical data or trial results are provided in the source material, but the analysis of four randomized clinical trials offers insights into the effectiveness of various smoking cessation strategies.

Key Findings

  • Four randomized clinical trials were analyzed, comprising 23 intervention arms focused on smoking cessation.
  • Interventions included counseling and pharmacotherapy, with varying intensities of support.
  • Short-term cost per quit and long-term cost-effectiveness were assessed for different cessation strategies.
  • The analysis linked empirical trial data with microsimulation models to project health and economic outcomes.
  • High-quality evidence on short-term cessation outcomes was obtained, although long-term consequences were not assessed in every trial.

Clinical Implications

Healthcare providers should consider integrating evidence-based smoking cessation strategies into lung cancer screening protocols.

Conclusion

The economic evaluation of smoking cessation strategies within lung cancer screening programs highlights the need for further research on the effectiveness of tailored interventions.

Related Resources & Content

  1. Fu et al, JAMA Pulmonary Medicine, 2023 -- Optimizing Tobacco Cessation Treatment With Lung Cancer Screenings
  2. The ASCO Post, 2022 -- Study Finds High-Intensity Intervention Helped One-Third of Participants in Lung Cancer Screening Program to Quit Smoking
  3. The ASCO Post, 2023 -- Lung Cancer Screening May Be More Cost-Effective When Using Risk Model–Based Strategies
  4. US Preventive Services Taskforce -- Recommendation: Lung Cancer: Screening
  5. The ASCO Post — Lung Cancer Screening and Possible Unappreciated Benefits
  6. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening
  7. Smoking Cessation Interventions in the Lung Cancer Screening Setting: A Randomized Clinical Trial
  8. Recommendation: Lung Cancer: Screening | United States Preventive Services Taskforce

Original Source(s)

Related Content